Interim report 2018-01-01 – 2018-06-30
The Board and Chief Executive Officer of Cereno Scientific AB herewith present the interim report for the second quarter 2018.Summary of the interim report Six months (2018-01-01 – 2018-06-30) · Net sales were 0 SEK (0 SEK). · Loss after financial items was -4 908 504 SEK (- 1 857 958). · Loss per share was -0,45 SEK (-0,17 SEK) before dilution and -0,42 SEK (-0,16 SEK) after dilution. · Equity ratio was 59,2 % (91,9 %). Three months (2018-04-01 – 2018-06-30) · Net sales were 0 SEK (0 SEK). · Loss after financial items was -3 103 061 SEK (-1 118 555 SEK). ·